Cysteine protease inhibitors and their therapeutic applications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8648076
APP PUB NO 20090215786A1
SERIAL NO

11997765

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HYBRIGENICS SA3/5 IMPASSE REILLE 75014 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boissy, Guillaume Vincennes, FR 3 8
Borg-Capra, Catherine Surenes, FR 4 8
Colland, Frédéric Puiseux en France, FR 14 37
Colombo, Matteo Camnago, IT 8 43
Daviet, Laurent Vetraz Monthoux, FR 19 30
Delansorne, Rémi Paris, FR 4 3
Formstecher, Etienne Paris, FR 6 15
Guedat, Philippe Montenois, FR 26 45
Jacq, Xavier Paris, FR 12 35
Rain, Jean-Christophe Ermont, FR 18 99
Vallese, Stefania Gallarate, IT 10 68

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 11, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00